Most recent report for North America, USA
http://www.promedmail.org/post/20181219.6215764
communicated by:
ProMED-mail rapporteur Mary Marshall
[So far in 2018, there are 165 confirmed cases of AFM in 36 states. These 165 confirmed cases are among the total of 320 reports that CDC received of patients under investigation (PUIs). CDC and state and local health departments are still investigating some of these PUIs.
There are multiple viral pathogens implicated in etiology for AFM, yet the exact diagnosis remains a challenge with low detection rates in spinal fluid; CDC reported detection of Coxsackievirus A16, EV-A71, and EV-D68 in the spinal fluid of four AFM cases out of 491 confirmed cases since 2014 (https://www.cdc.gov/acute-flaccid-myelitis/afm-surveillance.html).
For case management, in November 2014, CDC developed "Interim Considerations for Clinical Management of Patients with AFM", in consultation with national experts in infectious diseases, neurology, pediatrics, critical care medicine, public health epidemiology, and virology. After 4 years of best practices in patient care and treatment experience, this document was updated and released in November 2018 (https://www.cdc.gov/acute-flaccid-myelitis/hcp/clinical-management.html). - Mod.UBA
HealthMap/ProMED map available at:
United States: http://healthmap.org/promed/p/106]